The Journal of Neuroscience, February 11, 2009, 29(6):1657-1669; doi:10.1523/JNEUROSCI.2781-08.2009
Previous Article | Next Article 
Neurobiology of Disease
Involvement of TRPC Channels in CCL2-Mediated Neuroprotection against Tat Toxicity
Honghong Yao,1
Fuwang Peng,1
Navneet Dhillon,1
Shannon Callen,1
Sirosh Bokhari,1
Lisa Stehno-Bittel,1,2
S. Omar Ahmad,3
John Q. Wang,4 and
Shilpa Buch1
Departments of 1Molecular and Integrative Physiology, 2Physical Therapy and Rehabilitation Science, and 3Occupational Therapy and Therapeutic Science, University of Kansas Medical Center, Kansas City, Kansas 66160, and 4Department of Basic Medical Science, University of Missouri–Kansas City School of Medicine, Kansas City, Missouri 64108
Correspondence should be addressed to Dr. Shilpa Buch, Department of Molecular and Integrative Physiology, 5000 Wahl Hall East, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160. Email: sbuch{at}kumc.edu
Chemokine (C-C motif) ligand 2 (CCL2), also known as monocyte chemoattractant protein-1, plays a critical role in leukocyte recruitment and activation. In the present study, we identify an additional role for CCL2 that of neuroprotection against HIV-1 transactivator protein (Tat) toxicity in rat primary midbrain neurons. Furthermore, we report the involvement of transient receptor potential canonical (TRPC) channels in CCL2-mediated neuroprotection. TRPC are Ca2+-permeable, nonselective cation channels with a variety of physiological functions. Blockage of TRPC channels resulted in suppression of both CCL2-mediated neuroprotection and intracellular Ca2+ elevations. Parallel but distinct extracellular signal-regulated kinase (ERK)/cAMP response element-binding protein (CREB) and Akt/nuclear factor
B (NF-
B) pathways were involved in the CCL2-mediated neuroprotection. Blocking TRPC channels and specific downregulation of TRPC channels 1 and 5 resulted in suppression of CCL2-induced ERK/CREB activation but not Akt/NF-
B activation. In vivo relevance of these findings was further corroborated in wild-type and CCR2 knock-out mice. In the wild-type but not CCR2 knock-out mice, exogenous CCL2 exerted neuroprotection against intrastriatal injection of HIV-1 Tat. These findings clearly demonstrate a novel role of TRPC channels in the protection of neurons against Tat through the CCL2/CCR2 axis.
Key words: CCL2; TRPC; midbrain neurons; Ca2+; ERK; Akt
Received June 18, 2008;
revised Oct. 31, 2008;
accepted Dec. 24, 2008.
Correspondence should be addressed to Dr. Shilpa Buch, Department of Molecular and Integrative Physiology, 5000 Wahl Hall East, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160. Email: sbuch{at}kumc.edu